跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kryxana - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kryxana
Approved
STANDARD
Kryxana
Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
41850819063b0f05
Company
Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
Type
Standard
Approval Details
Approval Id
41850819063b0f05
Drug Approval Philippines Name
Kryxana
Product Name
Kryxana
Registration Number
DR-XY46426
Brand Name
Kryxana
Generic Name
Ribociclib (As Succinate)
Dosage Form
Film-Coated Tablet
Dosage Strength
200 mg
Manufacturer
Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.
Importer
Sandoz Philippines Corporation
Distributor
Sandoz Philippines Corporation
Issuance Date
25 August 2022
Expiry Date
25 August 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
41850819063b0f05
Type
Standard
Back to Philippines FDA Approvals